The rising prevalence of cardiovascular, renal, and neurovascular diseases has increased the demand for long-term IV therapies like medication, dialysis, and fluid management. Chronic patients frequently need venous access, but traditional central venous methods carry risks such as infections and clotting. Midline catheters offer a safer, minimally invasive alternative, staying in place for weeks and reducing the need for multiple needle insertions while lowering the risk of bloodstream infections and vein thrombosis, making them ideal for patients requiring ongoing care without central access. This alarming statistic underscores the rising prevalence of chronic diseases, highlighting the urgent need for effective medical interventions. As the demand for reliable vascular access solutions like midline catheters increases in response to the growing incidence of CVDs, this trend is expected to drive the EMEA midline catheter market significantly.
The rising prevalence of chronic conditions like cardiovascular, renal, and neurovascular disorders is driving demand for midline catheters across the EMEA region. Healthcare providers are adopting these minimally invasive solutions to improve patient outcomes, reduce infections, and lower treatment costs, fueling strong market growth for reliable long-term intravenous access.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/emea-midline-catheter-market
Data Bridge Market Research analyzes that the EMEA Midlines Catheter Market is expected to reach USD 265.55 million by 2031, from USD 180.96 million in 2023, growing at a CAGR of 5.6% in the forecast period of 2024 to 2031.
Key Findings of the Study
Increasing Demand for Vascular Access Devices
The increasing demand for vascular access devices presents significant opportunities for the midline catheter market, particularly in the EMEA region. As chronic diseases such as diabetes, cancer, and cardiovascular conditions rise, healthcare providers face a growing need for effective and reliable vascular access solutions. The shift towards minimally invasive procedures in healthcare settings further enhances the appeal of midline catheters. As healthcare professionals increasingly prioritize patient-centered care, midline catheters become a preferred choice, driving their adoption in both hospital and outpatient settings.
Therefore, the focus on patient safety and infection control is prompting healthcare providers to adopt devices with lower risks of complications. Midline catheters, known for their reduced incidence of infection and better patient outcomes, align well with this trend. As educational initiatives around the proper use and benefits of midline catheters increase, they will likely become more integrated into standard treatment protocols, further driving market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Application (Oncology, Cardiovascular, Urology, Neurovascular, and Specialty), Design (Single Lumen and Double Lumen), Lumen Gauge (18 G, 20 G, 19 G, and Others), Technique (Seldinger's Technique and Ultrasonography), Age Group (Adult, Pediatric, and Geriatric), End User (Hospital, Specialty Clinic, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others)
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
BD (U.S.), Teleflex Incorporated. (U.S.), Argon Medical Devices (U.S.), ICU Medical, Inc. (U.S.), Vygon (U.S.), AngioDynamics, Inc. (U.S.), Haolang Technology (Foshan) Limited Co., Ltd. (China), Deltamed (Italy), Seda S.p.A (Italy), Harsoria Healthcare Pvt Ltd (Egypt), PFM Medical, Inc. (U.S.), Medical Component Inc. (U.S.), Kimal (U.S.), Amecath (Egypt), Healthline Medical Products (U.S.), and Helmeir (India) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
EMEA midlines catheter market is segmented into seven notable segments which are based on application, design, lumen gauge, technique, age group, end user, and distribution channel.
- On the basis of application, the market is segmented into oncology, cardiovascular, urology, neurovascular, and specialty
In 2024, the oncology segment is expected to dominate the EMEA midlines catheter market
In 2024, the oncology segment is expected to dominate the midlines catheter market with a market share of 44.03% and 45.25% in Europe and Middle East & Africa respectively due to the rising incidence of cancer and the need for long-term intravenous access for chemotherapy and other treatments, which necessitates reliable and safe vascular access solutions.
- On the basis of design, the market is segmented into single lumen and double lumen
In 2024, the single lumen segment is expected to dominate the EMEA midlines catheter market
In 2024, the single lumen segment is expected to dominate the midlines catheter market with a market share of 59.06% and 59.95% in Europe and Middle East & Africa respectively due to its simplicity, ease of use, and lower risk of complications, making it a preferred choice for many healthcare providers when managing intravenous therapies.
- On the basis of lumen gauge, the market is segmented into 18 G, 20 G, 19 G, and others. In 2024, the 18 G segment is expected to dominate the midlines catheter market with a market share of 58.72% and 59.62% in Europe and Middle East & Africa respectively
- On the basis of technique, the market is segmented into seldinger's technique, and ultrasonography. In 2024, the seldinger's technique segment is expected to dominate the midlines catheter market with market share of 58.10% and 59.02% in Europe and Middle East & Africa respectively
- On the basis of age group, the market is segmented into adult, geriatric, and pediatric. In 2024, the adult segment is expected to dominate the midlines catheter market with a market share of 58.52% and 59.63% in Europe and Middle East & Africa respectively
- On the basis of end user, the market is segmented into hospital, specialty clinic, ambulatory surgical centers, and others. In 2024, the hospital segment is expected to dominate the midlines catheter market with a market share of 51.80% and 52.86% in Europe and Middle East & Africa respectively
- On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and others. In 2024, the direct tenders segment is expected to dominate the midlines catheter market with a market share of 61.12% and 61.97% in Europe and Middle East & Africa respectively
Major Players
Data Bridge Market Research analyzes BD (U.S.), Teleflex Incorporated. (U.S.), Argon Medical Devices (U.S.), ICU Medical, Inc. (U.S.), Vygon (U.S.) as the major players operating in the Europe midlines catheter market.
Data Bridge Market Research analyzes BD (U.S.), Teleflex Incorporated. (U.S.), Argon Medical Devices (U.S.), ICU Medical, Inc. (U.S.), AngioDynamics, Inc. (U.S.) as the major players operating in the Middle East & Africa midlines catheter market.
Market Development
- In October 2024, BD has launched a new robotics solution to automate and standardize single-cell research, enhancing efficiency and accuracy in the analysis of cellular behavior and interactions for advanced scientific studies
- In February 2024, AngioDynamics, Inc. has sold its PICC and Midline product portfolios to Spectrum Vascular for up to USD 45 million in cash. This sale, which included products generating approximately USD 43.5 million in annual sales, follows the discontinuation of AngioDynamics’ Uniblate, Starburst Radio Frequency, and Syntrax support catheter products, totaling around USD 5.5 million in annual sales
- In March 2022, Vygon has acquired Macatt Medica, enhancing its distribution capabilities in Peru. This acquisition strengthens Vygon's presence in South America, allowing for a wider range of enteral nutrition products and reinforcing collaboration with its Colombian branch to better serve regional customers
- In January 2022, ICU Medical, inc. completed its acquisition of Smiths Medical from Smiths Group plc. This addition enhanced ICU Medical's portfolio with syringe and ambulatory infusion devices, creating a leading infusion therapy company with estimated combined revenues of approximately USD 2.5 billion
- In December 2021, Argon Medical Devices, Inc. has acquired Matrex Mold and Tool, Inc., enhancing its production capabilities for medical devices. This strategic move aims to improve product quality, reduce time-to-market, and support both existing and new customers in various industries
Regional Analysis
Geographically, the countries covered in the EMEA midlines catheter market report are the Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, and rest of Europe, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
Europe is the dominant and fastest growing region in the EMEA midlines catheter market
Europe is dominant and fastest growing region in the market due to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and increasing emphasis on patient-centric care, which drives demand for effective and reliable intravenous access solutions.
For more detailed information about the EMEA Midlines Catheter market report, click here – https://www.databridgemarketresearch.com/ar/reports/emea-midline-catheter-market
